ForSight VISION5 Finds $15M
Menlo Park-based Forsight VISION5, a developer of ocular inserts for treating glaucoma, dry eye, and allergy, said yesterday that it has raised $15M in a Series C funding round. The funding came from H.I.G. BioVentures, as well as Morgenthaler Ventures, Versant Ventures, Technology Partners, and Delphi Ventures.
posted on Thursday, April 17, 2014 (Link to more information)
Related companies:
ForSight Labs
Related stories:
> ForSight VISION5 Sees $9.3M
> ForSight VISION3 Sees $6M
> ForSight Labs Raises $5M
> Transcend Medical Sees $51M
> Prismatic Finds $15M For Personalized News
silicontap.com Home